Matches in SemOpenAlex for { <https://semopenalex.org/work/W2032992014> ?p ?o ?g. }
Showing items 1 to 92 of
92
with 100 items per page.
- W2032992014 endingPage "53" @default.
- W2032992014 startingPage "48" @default.
- W2032992014 abstract "Biological therapy for moderate to severe psoriasis includes tumour necrosis factor (TNF) blockers (infliximab, etanercept and adalimumab) and T-cell-targeting agents (efalizumab, alefacept) that act in different steps of a common pathogenic pathway. Large amounts of data coming from clinical trials indicate each of these drugs as highly effective and safe. However, little is known about the efficacy of a second biological therapy after the failure of the first.To evaluate whether the response to efalizumab in psoriasis patients was influenced by previous treatment with other biological agents.We have retrospectively analyzed a group of 155 psoriasis patients treated with efalizumab during the last 5 years and determined its efficacy in patients previously treated with anti-TNF drugs comparing it with the efficacy and safety observed in patients previously treated with traditional systemic drugs instead.Efalizumab was shown to be as efficacious and safe in patients previously treated with biological agents as in those previously treated with traditional systemic drugs. Although not statistically significant, we observed a higher rate of response to efalizumab in patients previously treated with anti-TNF-alpha. PASI 75 was achieved at week 24 in 76.2% of the patients previously treated with biological agents versus 54.4% in patients previously treated with traditional drugs (OR = 2.9).These data suggest that efalizumab can be successfully used in psoriasis patients when TNF blockers cannot efficiently control the disease due to lack or loss of response, or when they have to be interrupted for intolerance or adverse events." @default.
- W2032992014 created "2016-06-24" @default.
- W2032992014 creator A5025847886 @default.
- W2032992014 creator A5036267976 @default.
- W2032992014 creator A5046567040 @default.
- W2032992014 creator A5053176930 @default.
- W2032992014 creator A5065367798 @default.
- W2032992014 creator A5085697674 @default.
- W2032992014 date "2009-01-01" @default.
- W2032992014 modified "2023-09-27" @default.
- W2032992014 title "Efficacy of Efalizumab in Psoriasis Patients Previously Treated with Tumour Necrosis Factor Blockers" @default.
- W2032992014 cites W122352342 @default.
- W2032992014 cites W123093596 @default.
- W2032992014 cites W1556049736 @default.
- W2032992014 cites W1922511603 @default.
- W2032992014 cites W1991386344 @default.
- W2032992014 cites W2018705890 @default.
- W2032992014 cites W2023639945 @default.
- W2032992014 cites W2023938460 @default.
- W2032992014 cites W2031317816 @default.
- W2032992014 cites W2052383963 @default.
- W2032992014 cites W2074537821 @default.
- W2032992014 cites W2080165152 @default.
- W2032992014 cites W2089246635 @default.
- W2032992014 cites W2098426281 @default.
- W2032992014 cites W2122265491 @default.
- W2032992014 cites W2141008039 @default.
- W2032992014 cites W2152721471 @default.
- W2032992014 cites W2413043776 @default.
- W2032992014 cites W2460286564 @default.
- W2032992014 cites W40775782 @default.
- W2032992014 cites W1972679306 @default.
- W2032992014 doi "https://doi.org/10.1159/000213758" @default.
- W2032992014 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/19372639" @default.
- W2032992014 hasPublicationYear "2009" @default.
- W2032992014 type Work @default.
- W2032992014 sameAs 2032992014 @default.
- W2032992014 citedByCount "3" @default.
- W2032992014 countsByYear W20329920142017 @default.
- W2032992014 crossrefType "journal-article" @default.
- W2032992014 hasAuthorship W2032992014A5025847886 @default.
- W2032992014 hasAuthorship W2032992014A5036267976 @default.
- W2032992014 hasAuthorship W2032992014A5046567040 @default.
- W2032992014 hasAuthorship W2032992014A5053176930 @default.
- W2032992014 hasAuthorship W2032992014A5065367798 @default.
- W2032992014 hasAuthorship W2032992014A5085697674 @default.
- W2032992014 hasConcept C126322002 @default.
- W2032992014 hasConcept C16005928 @default.
- W2032992014 hasConcept C17991360 @default.
- W2032992014 hasConcept C197934379 @default.
- W2032992014 hasConcept C2777011040 @default.
- W2032992014 hasConcept C2777138892 @default.
- W2032992014 hasConcept C2777226972 @default.
- W2032992014 hasConcept C2780132546 @default.
- W2032992014 hasConcept C2780564577 @default.
- W2032992014 hasConcept C2780969348 @default.
- W2032992014 hasConcept C71924100 @default.
- W2032992014 hasConcept C98274493 @default.
- W2032992014 hasConceptScore W2032992014C126322002 @default.
- W2032992014 hasConceptScore W2032992014C16005928 @default.
- W2032992014 hasConceptScore W2032992014C17991360 @default.
- W2032992014 hasConceptScore W2032992014C197934379 @default.
- W2032992014 hasConceptScore W2032992014C2777011040 @default.
- W2032992014 hasConceptScore W2032992014C2777138892 @default.
- W2032992014 hasConceptScore W2032992014C2777226972 @default.
- W2032992014 hasConceptScore W2032992014C2780132546 @default.
- W2032992014 hasConceptScore W2032992014C2780564577 @default.
- W2032992014 hasConceptScore W2032992014C2780969348 @default.
- W2032992014 hasConceptScore W2032992014C71924100 @default.
- W2032992014 hasConceptScore W2032992014C98274493 @default.
- W2032992014 hasIssue "1" @default.
- W2032992014 hasLocation W20329920141 @default.
- W2032992014 hasLocation W20329920142 @default.
- W2032992014 hasOpenAccess W2032992014 @default.
- W2032992014 hasPrimaryLocation W20329920141 @default.
- W2032992014 hasRelatedWork W1958224858 @default.
- W2032992014 hasRelatedWork W2050528164 @default.
- W2032992014 hasRelatedWork W2069872226 @default.
- W2032992014 hasRelatedWork W2071306106 @default.
- W2032992014 hasRelatedWork W2147572249 @default.
- W2032992014 hasRelatedWork W2737526559 @default.
- W2032992014 hasRelatedWork W2936224517 @default.
- W2032992014 hasRelatedWork W2978616557 @default.
- W2032992014 hasRelatedWork W652372340 @default.
- W2032992014 hasRelatedWork W6525474 @default.
- W2032992014 hasVolume "219" @default.
- W2032992014 isParatext "false" @default.
- W2032992014 isRetracted "false" @default.
- W2032992014 magId "2032992014" @default.
- W2032992014 workType "article" @default.